10-K: ParkerVision Faces Going Concern Doubt Amid Patent Litigation Focus

ParkerVision, Inc. reported significant losses and negative cash flows for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern, as it continues to rely heavily on patent enforcement litigation for future revenue.

Summary

• ParkerVision's primary business is innovating and licensing fundamental wireless technologies, with a current focus on enforcing intellectual property rights through patent infringement litigation.
• The company reported a net loss of $7.4 million for the year ended December 31, 2025, compared to $14.5 million in 2024.
• Cash and cash equivalents stood at $4.4 million at December 31, 2025, with working capital of $2.3 million and an accumulated deficit of $455.6 million.
• The independent registered public accounting firm expressed substantial doubt about the company's ability to continue as a going concern.
• No licensing revenue was reported for 2025 or 2024.
• Selling, general, and administrative expenses increased by 78% to $7.6 million in 2025, primarily due to a $2.9 million increase in share-based compensation and a $0.8 million increase in consulting and lobbying fees.
• The company has five licensees, all resulting from patent enforcement efforts, with one-time, up-front payments and no recurring revenue.
• Significant litigation is ongoing, including nine patent enforcement actions in the Western District of Texas, an expedited appeal against Qualcomm, and several Inter Partes Review (IPR) actions.
• Litigation costs are largely funded by secured contingent payment arrangements with Brickell Key Investments, LP, and contingent fee arrangements with legal counsel, which will consume a significant portion of future proceeds.
• The company issued 3.3 million shares of common stock in March 2026 to satisfy $0.7 million in convertible debt and accrued interest.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative report. The company faces severe financial challenges, including a going concern doubt, no revenue, and heavy reliance on unpredictable litigation outcomes, with significant portions of any future proceeds already committed to funders and legal fees. While some litigation appeals are progressing, the overall financial health is precarious.

Positives

• Net loss decreased from $14.5 million in 2024 to $7.4 million in 2025.
• Working capital improved to $2.3 million at December 31, 2025.
• The CAFC granted an expedited appeal in the Qualcomm patent infringement action in January 2026, following a favorable opinion and remand in 2024.
• The company successfully defended against two IPR petitions filed by Realtek in June 2025, which were denied due to being time-barred.
• The Board has oversight of all enterprise risks, including cybersecurity, and has an informal cyber incident response plan.
• Management concluded that disclosure controls and procedures and internal control over financial reporting were effective as of December 31, 2025.

Negatives

• Substantial doubt exists about the company's ability to continue as a going concern due to significant losses and negative cash flows since inception, and an accumulated deficit of $455.6 million.
• No licensing revenue was reported for the years ended December 31, 2025, and 2024.
• Cash used for operations increased from $3.2 million in 2024 to $5.1 million in 2025.
• Selling, general, and administrative expenses increased by 78% to $7.6 million in 2025, driven by higher share-based compensation and consulting fees.
• A significant portion (up to 100% initially, then at least 75%) of future patent-related proceeds will be used to repay contingent payment arrangements, limiting funds for operations.
• The company anticipates making future interest payments on convertible notes in shares of common stock, leading to further shareholder dilution.
• The district court's claim construction order in May 2025 for the Qualcomm case essentially precluded the company from asserting its receiver claims, necessitating another appeal.
• The PTAB issued an unfavorable final written decision in November 2025 in one IPR filed by Texas Instruments, deeming challenged patent claims unpatentable.
• The company's petition to the U.S. Supreme Court with respect to two unfavorable PTAB decisions that were upheld by the CAFC was denied on March 24, 2025.
• The company has ceased research and development activities due to limited financial resources, which could result in a loss of future market opportunity.
• The common stock is quoted on OTCQB, a limited market, and has been classified as a "penny stock" in prior periods, which could affect liquidity and capital raising ability.

Risks

• Financial condition raises substantial doubt about the ability to continue as a going concern, potentially leading to liquidation at lower asset values and affecting ability to raise capital.
• Consistent significant losses and negative cash flows may compromise the business plan and ability to meet obligations.
• Will require substantial additional capital to fund operations; failure to raise it may prevent business plan implementation.
• Issuing debt or equity may result in dilution, operational limitations, covenants, or payment obligations.
• Obligation to repay outstanding notes at a premium upon an event of default, with insufficient funds potentially available.
• Ability to utilize $254.7 million in NOLs and $3.5 million in R&D credits could be limited by insufficient income or an ownership change under Section 382.
• Contingent funding arrangements consume initial future proceeds (up to 100% initially, then at least 75%), impairing ability to obtain future financing and support operations.
• Litigation is time-consuming, costly, and results are uncertain; unfavorable outcomes could exhaust financial resources and hinder future opportunities.
• Challenges to patents (e.g., IPRs) could invalidate claims, leading to loss of competitive advantage and adverse financial impact.
• Future pandemics or similar outbreaks could cause market volatility, impact capital raising, and delay patent enforcement/licensing programs.
• New legislation or regulations related to patents could adversely affect licensing and enforcement activities.
• Cessation of R&D activities due to limited resources could lead to a loss of future market opportunity.
• Loss of Jeffrey Parker's services might be seen as an impediment to the execution of the business plan due to his leadership, industry relationships, and role in litigation strategies.
• Inability to retain skilled and specialized key employees would have an adverse impact on technical support, financial reporting, and regulatory compliance activities.
• Reliance on information technology systems and third-party providers exposes the company to cyber threats, potentially leading to operational interruptions, reputation damage, litigation, and costly response measures.
• The trading price of common stock has been and may continue to be volatile due to litigation, performance, market conditions, and other factors.
• Trading on OTCQB results in a less liquid market; potential reclassification as a "penny stock" could further limit trading and capital raising.
• Shareholders must rely on stock appreciation for gains, as the company does not currently pay dividends, and appreciation is not assured.
• Provisions in the certificate of incorporation and by-laws, such as a staggered Board and ability to issue preferred stock without shareholder approval, could make it more difficult for a third party to acquire control.

Future Outlook

The company expects to continue investing in its patent enforcement and licensing programs, but anticipates that cash flows from these activities in 2026, after contingent payment obligations, may not be sufficient to cover operating expenses and debt repayment. Additional capital will be required if sufficient revenues or patent-related proceeds are not generated. Future interest payments on convertible notes are anticipated to be made in shares of common stock. The long-term continuation of the business plan is dependent on securing sufficient financing and generating enough revenue/proceeds to offset expenses and meet obligations. Several ongoing legal proceedings have upcoming milestones, including expected PTAB decisions in March and May 2026, oral arguments for the Qualcomm appeal after March 2026, and trials scheduled for April 2026 and April 2027.

Management Comments

• "We believe certain patents protecting our proprietary technologies have been broadly infringed by others and therefore the primary focus of our current business plan is the enforcement of our intellectual property rights through licensing efforts and patent infringement litigation efforts."
• "We have made significant investments in developing and protecting our technologies, the returns on which are dependent upon the generation of future revenues for realization."
• "We continue to aggressively pursue licensing opportunities with wireless communications companies that make, use or sell semiconductors and/or products that incorporate RF technologies."
• "We believe there are a number of wireless communications companies that can benefit from the use of the RF technologies we have developed, whether through a license or, in certain cases, a joint product venture that may include licensing rights."
• "Our licensing efforts to date have required litigation in order to enforce and/or defend our intellectual property rights."
• "We currently do not believe that we will have the financial ability to make payments on the notes in cash when due. Accordingly, we currently intend to make such payments in shares of our common stock to the greatest extent possible."
• "Our management, with the oversight of our Board of Directors ('Board'), monitors the hiring, retention, and management of our employees."
• "Our compensation committee considers whether there is any material nonpublic information ('MNPI') about our company when determining the timing of equity awards and does not seek to time the grant of equity awards in relation to our public disclosure of MNPI. We have not timed the release of MNPI for the purpose of affecting the value of executive compensation."

Industry Context

StockSavvy.ai notes that ParkerVision's singular focus on patent enforcement and licensing, particularly in the wireless technology sector, highlights a common strategy for intellectual property-rich companies facing market penetration challenges or seeking to monetize extensive R&D investments. The ongoing, complex, and costly litigation against major players like Qualcomm, Apple, MediaTek, and Texas Instruments is typical for patent assertion entities in the highly competitive and litigious semiconductor and mobile communications industries. The lack of recurring revenue and reliance on one-time settlements underscore the inherent volatility and unpredictability of this business model compared to companies with product-based revenue streams.

Comparison to Industry Standards

• The company's accumulated deficit of $455.6 million and consistent net losses are significantly below industry standards for profitable technology companies.
• The reliance on litigation funding, where up to 100% of initial proceeds are consumed by obligations, is a common but high-cost financing model for patent assertion entities, contrasting sharply with established tech firms that fund R&D and operations through product sales and recurring revenue.
• The absence of licensing revenue for two consecutive years (2024 and 2025) is a critical underperformance compared to successful IP licensing firms that generate consistent revenue streams.
• The company's market capitalization of approximately $29.6 million (as of June 30, 2025) and trading on OTCQB indicate a micro-cap status, far below the valuations of the large, publicly traded technology companies it is litigating against (e.g., Qualcomm, Apple, LG, MediaTek, Texas Instruments, NXP Semiconductors), which typically have market caps in the billions or trillions.
• The increase in SG&A expenses by 78% in 2025, largely due to share-based compensation and consulting fees, without corresponding revenue, is a negative divergence from industry best practices for cost management in a non-revenue generating environment.

Management Changes

Corporate Governance

Legal Proceedings

• **ParkerVision v. Qualcomm (Middle District of Florida-Orlando Division):** Second appeal underway at the U.S. Court of Appeals for the Federal Circuit (CAFC). The case was remanded in 2024 after a favorable CAFC opinion. The district court's May 2025 claim construction order again precluded receiver claims, leading to a new expedited appeal to the CAFC. Oral arguments are expected after March 2026.
• **ParkerVision v. Apple and Qualcomm (Middle District of Florida-Jacksonville Division):** Stayed since April 2020 pending the outcome of the infringement case against Qualcomm in the Orlando Division.
• **ParkerVision v. LG (District of New Jersey):** Stayed since March 2018 pending a final decision in ParkerVision v. Apple and Qualcomm.
• **ParkerVision v. Realtek (Western District of Texas):** Two cases combined into a single trial scheduled for April 27, 2026, narrowed to an aggregate of three patents. Claim construction hearings were held in January and June 2024, with the court adopting the majority of the company's constructions.
• **ParkerVision v. TCL (Western District of Texas):** Stayed since January 2023 pending final resolution of patent infringement actions filed against Realtek.
• **ParkerVision v. MediaTek (Western District of Texas):** The trial for the first case, scheduled for March 20, 2026, was postponed on March 16, 2026, pending updates to expert reports. The second case is stayed pending a PTAB decision (expected May 2026). The third case has a trial scheduled for April 2027.
• **ParkerVision v. LGE (Western District of Texas):** Stayed since January 2023 pending final resolution of actions against Realtek and MediaTek, as well as IPR actions.
• **ParkerVision v. Texas Instruments (Western District of Texas):** Stayed since May 2025 pending the PTAB's final written decision on IPRs filed against all of the patents in this case.
• **ParkerVision v. NXP Semiconductors (Western District of Texas):** Stayed since May 2025 pending the PTAB's final written decision on IPRs filed against all of the patents in this case.
• **TCL and LGE v. ParkerVision (PTAB):** The CAFC affirmed PTAB rulings in June 2024 that challenged claims for U.S. patent 7,292,835 and U.S. patent 7,110,444 were unpatentable. The U.S. Supreme Court denied the company's petition for a Writ of Certiorari on March 24, 2025.
• **MediaTek v. ParkerVision (PTAB):** One IPR petition was terminated in September 2024 after the company dismissed the related patent from the infringement action. A second IPR was instituted in November 2024, with a decision extended to May 2026. A third IPR was instituted in March 2025, with a final decision expected in March 2026.
• **Texas Instruments and NXP v. ParkerVision (PTAB):** Three IPRs were instituted by TI in November 2024. NXP joined the TI petitions. The PTAB issued a final written decision in November 2025 in one IPR, deeming challenged patent claims unpatentable; the company filed a request for director review. Deadlines for two joint TI/NXP IPRs were extended to May 2026.
• **Realtek v. ParkerVision (PTAB):** Two IPR petitions filed by Realtek in December 2024 were denied by the PTAB in June 2025 as time-barred.
• **Goldberg Segalla v. ParkerVision (Arbitration):** Arbitration resumed in January 2026 for $4.3 million in disputed contingency fees and advances. The company denied allegations and asserted affirmative defenses, and is indemnified by Daignault Iyer, LLP and Brickell for these claims.

Related Party Transactions

• On November 17, 2025, Lewis H. Titterton, an independent director, purchased 4,761,905 shares of common stock at $0.21 per share for gross proceeds of $1.0 million in a registered direct offering.
• Convertible notes held by Mr. Lewis Titterton (prior to becoming a director) were converted into shares of common stock in May 2025. As of December 31, 2025, Mr. Titterton holds no outstanding convertible notes.
• Convertible notes held by Mr. Paul Rosenbaum were converted into shares of common stock in October 2024.
• The company paid approximately $42,000 in 2025 and $39,000 in 2024 for patent-related legal services to Sterne, Kessler, Goldstein, & Fox, PLLC (SKGF), of which Robert Sterne (independent director) is a partner.
• The company paid approximately $150,000 in both 2025 and 2024 for principal and interest on a note payable to SKGF. The SKGF note has an outstanding balance, including accrued interest, of approximately $201,000 at December 31, 2025.

Stakeholder Impact

• **Shareholders:** Face significant dilution risk from future equity raises, conversion of convertible notes, and in-kind interest payments. Investment value is highly dependent on successful litigation outcomes, which are uncertain. The "going concern" doubt poses a fundamental risk to their investment. Trading on OTCQB and potential "penny stock" status limit liquidity.
• **Employees/Executives:** Base salaries for CEO and CFO increased in April 2025. Executives received performance-based and time-based stock options in January 2026. Existing options for CEO and CFO had expiration dates extended. However, the company's overall financial instability and going concern doubt create job security risks.
• **Creditors (Litigation Funders/Note Holders):** Brickell Key Investments, LP, and other contingent funders have priority claims on future patent-related proceeds, potentially consuming up to 100% of initial proceeds. Convertible note holders have the option to convert debt into common stock, but the company anticipates making interest payments in shares, which could be less favorable than cash. The going concern doubt increases repayment risk.
• **Legal Counsel:** Many legal fees are contingent upon successful litigation outcomes, creating uncertainty in payment. The arbitration with Goldberg Segalla highlights potential disputes over fees.

Next Steps

• The court will issue a revised pretrial and trial schedule for the MediaTek patent enforcement trial following receipt of updated expert reports and briefings.
• Briefings for the expedited appeal in the Qualcomm patent infringement action are expected to be completed by March 2026, with oral arguments scheduled for the next available CAFC session thereafter.
• The company's final reply brief for the Qualcomm appeal is due to be filed on March 23, 2026.
• A final written decision for the third MediaTek IPR is currently expected in March 2026.
• The combined Realtek trial is scheduled to commence on April 27, 2026.
• PTAB decisions are expected by May 2026 for the second MediaTek IPR and two joint TI/NXP IPRs.
• A trial in the third MediaTek action is currently scheduled for April 2027.
• The company will need to raise additional capital if it does not generate sufficient revenues or patent-related proceeds.
• The company will continue to invest in the support of its patent enforcement and licensing programs.
• The company is evaluating the impact of new accounting guidance (ASU 2024-04) effective for periods beginning after December 15, 2025.

Key Dates

Recommendation

The company faces fundamental solvency issues, explicitly stated by its auditor as "substantial doubt about its ability to continue as a going concern." It has a history of significant losses and negative cash flows, with no licensing revenue reported for the past two years. The business model relies almost entirely on highly unpredictable and costly patent infringement litigation, with a large portion of any future proceeds already committed to litigation funders and legal counsel. This leaves minimal cash for operations and necessitates further dilutive capital raises. Recent litigation developments include postponements and unfavorable IPR decisions, adding to the uncertainty. The stock trades on a less liquid over-the-counter market, further increasing risk. Given these severe financial and operational challenges, the stock presents an extremely high-risk profile with a high probability of further value erosion.

Keywords

Patent enforcement, Wireless technology licensing, Intellectual property litigation, RF technologies, Going concern, SEC 10-K, ParkerVision, Cybersecurity risk, Convertible debt, Share-based compensation, Litigation funding, NOL carryforwards, OTCQB